INTEG B Share Price Performance
SEK 0
-42.80 (-100.00%)
Price SEK 0
Fair ValueSEK 36.50
Share Pricen/a
Integrum AB (publ) Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
INTEG B Community Narratives
AN
Fair Value
·Fair Value SEK 36.5 74.8% undervalued intrinsic discount
Regulatory Hurdles And US Momentum Will Shape Market Outlook
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Integrum
74.8% undervalued intrinsic discount
Regulatory Hurdles And US Momentum Will Shape Market Outlook
View narrativeAN
Updated 1 May 2025
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
Regulatory Hurdles And US Momentum Will Shape Market Outlook
Fair Value: SEK 36.5 74.8% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Integrum AB (publ) Key Details
Last Reported Earnings
Jul 31, 2026
Next Reporting Earnings
Dec 03, 2026
- -1.33
- 71.98%
- -36.26%
- 0%
About INTEG B
- Founded
- 1990
- Employees
- 33
- CEO
- WebsiteView website
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. It also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was incorporated in 1990 and is headquartered in Mölndal, Sweden.
